231 related articles for article (PubMed ID: 35536495)
1. Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson's disease: a preliminary evidence.
Liguori C; Fernandes M; Cerroni R; Ludovisi R; Mercuri NB; Stefani A; Pierantozzi M
Neurol Sci; 2022 Sep; 43(9):5355-5362. PubMed ID: 35536495
[TBL] [Abstract][Full Text] [Related]
2. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study.
Medeiros CA; Carvalhedo de Bruin PF; Lopes LA; Magalhães MC; de Lourdes Seabra M; de Bruin VM
J Neurol; 2007 Apr; 254(4):459-64. PubMed ID: 17404779
[TBL] [Abstract][Full Text] [Related]
3. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J
Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307
[TBL] [Abstract][Full Text] [Related]
4. [Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].
Litvinenko IV; Krasakov IV; Tikhomirova OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):26-30. PubMed ID: 23388588
[TBL] [Abstract][Full Text] [Related]
5. Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's disease.
Stauder M; Klerman EB; Wang W; Erickson H; Videnovic A
Parkinsonism Relat Disord; 2022 Aug; 101():57-61. PubMed ID: 35797857
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems in Parkinson Disease: An Open-Label Pilot Study.
Suzuki K; Funakoshi K; Fujita H; Hirata K
Clin Neuropharmacol; 2022 May-Jun 01; 45(3):61-64. PubMed ID: 35579485
[TBL] [Abstract][Full Text] [Related]
7. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease.
Videnovic A; Noble C; Reid KJ; Peng J; Turek FW; Marconi A; Rademaker AW; Simuni T; Zadikoff C; Zee PC
JAMA Neurol; 2014 Apr; 71(4):463-9. PubMed ID: 24566763
[TBL] [Abstract][Full Text] [Related]
8. Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease.
Liguori C; Mercuri NB; Albanese M; Olivola E; Stefani A; Pierantozzi M
J Neurol; 2019 Mar; 266(3):636-641. PubMed ID: 30607535
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine for insomnia in Parkinson disease: results from an open-label trial.
Juri C; Chaná P; Tapia J; Kunstmann C; Parrao T
Clin Neuropharmacol; 2005; 28(4):185-7. PubMed ID: 16062098
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Parkinson's disease sleep scale in Japanese patients: a comparison study using the Pittsburgh Sleep Quality Index, the Epworth Sleepiness Scale and Polysomnography.
Uemura Y; Nomura T; Inoue Y; Yamawaki M; Yasui K; Nakashima K
J Neurol Sci; 2009 Dec; 287(1-2):36-40. PubMed ID: 19804890
[TBL] [Abstract][Full Text] [Related]
11. Poor nighttime sleep is positively associated with dyskinesia in Parkinson's disease patients.
Mao CJ; Yang YP; Chen JP; Wang F; Chen J; Zhang JR; Zhang HJ; Zhuang S; Xiong YT; Gu CC; Yuan W; Huang JY; Fay A; Zhong CK; Liu CF
Parkinsonism Relat Disord; 2018 Mar; 48():68-73. PubMed ID: 29305084
[TBL] [Abstract][Full Text] [Related]
12. Istradefylline improves daytime sleepiness in patients with Parkinson's disease: An open-label, 3-month study.
Suzuki K; Miyamoto M; Miyamoto T; Uchiyama T; Watanabe Y; Suzuki S; Kadowaki T; Fujita H; Matsubara T; Sakuramoto H; Hirata K
J Neurol Sci; 2017 Sep; 380():230-233. PubMed ID: 28870576
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of melatonin, clonazepam, and trazodone in patients with Parkinson's disease and sleep disorders: a randomized, double-blind trial.
Hadi F; Agah E; Tavanbakhsh S; Mirsepassi Z; Mousavi SV; Talachi N; Tafakhori A; Aghamollaii V
Neurol Sci; 2022 Oct; 43(10):6141-6148. PubMed ID: 35660990
[TBL] [Abstract][Full Text] [Related]
14. Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR study.
Santos García D; Cabo López I; Labandeira Guerra C; Yáñez Baña R; Cimas Hernando MI; Paz González JM; Alonso Losada MG; Gonzalez Palmás MJ; Cores Bartolomé C; Martínez Miró C
Neurol Sci; 2022 Apr; 43(4):2537-2544. PubMed ID: 34554335
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis.
Rodrigues TM; Castro Caldas A; Ferreira JJ
Parkinsonism Relat Disord; 2016 Jun; 27():25-34. PubMed ID: 27010071
[TBL] [Abstract][Full Text] [Related]
16. A Pilot Study Assessing the Effects of Pallidal Deep Brain Stimulation on Sleep Quality and Polysomnography in Parkinson's Patients.
Tolleson CM; Bagai K; Walters AS; Davis TL
Neuromodulation; 2016 Oct; 19(7):724-730. PubMed ID: 27186939
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial.
Xu H; Zhang C; Qian Y; Zou J; Li X; Liu Y; Zhu H; Meng L; Liu S; Zhang W; Yi H; Guan J; Chen Z; Yin S
Sleep Med; 2020 Dec; 76():113-119. PubMed ID: 33157425
[TBL] [Abstract][Full Text] [Related]
18. Does gender differences have a role in determining sleep quality in Parkinson's disease?
Mahale R; Yadav R; Pal PK
Acta Neurol Belg; 2021 Aug; 121(4):1001-1007. PubMed ID: 32946048
[TBL] [Abstract][Full Text] [Related]
19. Daytime sleepiness in Parkinson's disease: a reappraisal.
Cochen De Cock V; Bayard S; Jaussent I; Charif M; Grini M; Langenier MC; Yu H; Lopez R; Geny C; Carlander B; Dauvilliers Y
PLoS One; 2014; 9(9):e107278. PubMed ID: 25198548
[TBL] [Abstract][Full Text] [Related]
20. Sleep disturbances in Taiwanese patients with Parkinson's disease.
Lin YY; Chen RS; Lu CS; Huang YZ; Weng YH; Yeh TH; Lin WY; Hung J
Brain Behav; 2017 Oct; 7(10):e00806. PubMed ID: 29075566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
